SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is seeing intense investor focus as the market awaits its upcoming quarterly earnings, with the community divided between those betting on an AI-driven breakout and those wary of its premium valuation. Conversations are dominated by debates over whether the company's enterprise software expansion and government contract momentum can justify its high valuation or if it faces a potential sell-the-news pullback.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle is trending following the OCC's final approval for the company to establish a federally regulated national trust bank, a milestone that community members are discussing as a significant step toward institutional legitimacy. While some traders are optimistic about this regulatory moat strengthening the long-term thesis for USDC, others remain cautious, highlighting ongoing concerns about competitive pressures and the stock's recent volatility.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is experiencing heightened investor interest ahead of its upcoming earnings report as market participants weigh recent price volatility against strong fundamental growth and market share expansion. The community is actively debating the stock's valuation, with many long-term holders viewing the current price levels as a significant accumulation opportunity despite persistent short-side pressure and macro-driven headwinds.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disney is trending as investors weigh strong theatrical box office performance from the Spider-Man franchise against broader media sector volatility and concerns regarding future earnings execution. Community discussions are split between excitement over high-grossing film releases and frustrations over long-term stock stagnation, with many market participants focused on upcoming guidance and potential streaming strategy shifts.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending as market participants closely watch the stock's transition from the NYSE to the NASDAQ and analyze the potential impact of its expanded commercial partnership with AT&T ahead of the upcoming second-quarter earnings report. Community discussions are heavily focused on the stock's technical support levels versus its long-term growth prospects, with many investors debating the company's competitive position in quantum annealing against broader sector-wide volatility and speculative interest.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox is facing significant downward pressure following a weak earnings report, where the withdrawal of full-year guidance and disappointing growth metrics triggered multiple analyst downgrades. The community is sharply divided, with many investors debating whether the current selloff presents a value-driven dip-buying opportunity or if the platform is experiencing a permanent lifecycle decline.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore is trending as investors weigh significant legal and regulatory catalysts, including upcoming court rulings on pipeline jurisdiction and ongoing discussions regarding federal energy support. While community sentiment is split between bullish long-term expectations tied to production growth and concerns over debt refinancing, the stock remains a focal point for those monitoring federal intervention in the domestic energy sector.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is currently trending as investors eagerly await Phase 3 IZAR-1 trial results, with the community closely tracking a clinical data readout previously guided for mid-summer. Sentiment remains divided between retail investors frustrated by the timeline and institutional followers who are closely analyzing trial design and clinical endpoints for signs of a best-in-class performance.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is currently experiencing significant volatility and heavy short interest, with community discourse heavily polarized between those anticipating a short squeeze fueled by strong steel fundamentals and skeptics questioning the company's debt management and leadership. Traders are actively debating the potential for an institutional accumulation phase and awaiting catalysts such as earnings reports and updates on high-profile partnership rumors.

REalloys, Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing. The company was founded on October 4, 2011 and is headquartered in Boca Raton, FL.

REalloys Inc.

REalloys Inc. is seeing intense investor activity driven by a strategic partnership with the U.S. Army to build heavy rare earth processing facilities on domestic military bases. The community is actively debating the company's long-term potential as a critical defense supplier in light of upcoming federal mandates that aim to eliminate dependence on Chinese rare earth materials.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Outlook Therapeutics’ Recently Approved Therapy Could Become Preferred Anti-VEGF Treatment Option In $8.5B US Retina Market, Says BTIG

Equity

BTIG upgraded the stock to ‘Buy’ from ‘Neutral’ after Outlook Therapeutics received regulatory approval for its wet AMD therapy.

Nasdaq Futures Lead US Premarket Rally As Iran Ceasefire Reports Ease Fears Ahead Of Big Tech Earnings: Why NVDA, ORCL, SPCX, XOM, OTLK Are In Focus 

Despite the futures rebound, retail investors remain cautious. Stocktwits data showed retail sentiment is ‘bearish’ on SPY and QQQ.


OTLK Stock Jumps Overnight After FDA Approval Of Wet AMD Drug — Analysts See Nearly 300% Upside 

Outlook expects a U.S. launch before year-end and anticipates 12 years of market exclusivity.

OTLK Stock Surges After FDA Ends Decade-Long Wait For Ophthalmic Bevacizumab

LYTENAVA is now the first and only FDA-approved version of the drug bevacizumab specifically made for injection into the eye to treat wet age-related macular degeneration. 


OTLK Stock Generates Buzz Ahead Of FDA Decision On Wet AMD Therapy – Retail Says Favorable Verdict Could Cause A ‘Big Boom’

After two rejections, retail investors are hopeful the FDA will approve Outlook Therapeutics’ Lytenava for the treatment of wet AMD.


OTLK Stock Up 35% as FDA Accepts Resubmitted Eye Drug BLA for Review

Outlook Therapeutics stock surges 35% after the FDA accepts the resubmitted Lytenava BLA for wet AMD for review, setting a July 29, 2026, decision date.

Outlook Therapeutics Eye Drug Review Returns To FDA For Fourth Time

Outlook Therapeutics shares rose after the FDA accepted its resubmitted LYTENAVA BLA and set a July 2026 target action date.read more...

OTLK Stock Soars 28% After FDA Sets July Date For Lytenava Decision

The agency will now decide whether to approve the drug by July 29, 2026.

OTLK Stock Surges On FDA Lytenava Application Resubmission After Successful Appeal  

A decision on the resubmitted application is expected within 60 days of the FDA’s receipt of it, the company said.


OTLK Stock Rocket Nearly 140%: Lytenava Dispute Resolution With FDA Pushes Stock On Track For Best Week On Record

Outlook Therapeutics wins appeal following formal dispute resolution process for LYTENAVA.

This account has been verified as an official OTLK representative.

Verified Account

Outlook Therapeutics

Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Iselin, NJ.

Outlook Therapeutics Inc

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$0.9766
Prev Close	$1.04
Open	$1.01
Dividend Yield	0.00%
50-Day Moving Average	$1.20
Beta	0.73
Avg. Volume	19.15M
PE Ratio	-0.89

52-Week High	$3.39
52-Week Low	$0.1611
Market Capitalization	$182.62M
EPS (Annual)	-$1.79
Price to Book	-3.52
Revenue Per Employee	$83,149.12

Feed

News

Sentiment

Earnings

Fundamentals

Info